
Aspira Women's Health AWH
Quarterly report 2025-Q3
added 11-14-2025
Aspira Women's Health P/S Ratio 2011-2025 | AWH
Annual P/S Ratio Aspira Women's Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.55 | 28.9 | 20 | 15.1 | 15.6 | 27.7 | 23.7 | 33.1 | 25.2 | 22.1 | 9.46 | 11.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 33.1 | 5.55 | 19.8 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
8.09 | $ 18.65 | -3.72 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
6.87 | $ 20.72 | -3.9 % | $ 223 M | ||
|
Co-Diagnostics
CODX
|
5.13 | $ 0.22 | -4.64 % | $ 6.46 M | ||
|
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
2.14 | $ 39.14 | -0.65 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
6.37 | $ 230.35 | - | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
2.13 | $ 10.65 | 6.03 % | $ 302 M | ||
|
BioNano Genomics
BNGO
|
0.115 | $ 1.5 | -1.45 % | $ 1.91 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
3.38 | $ 101.58 | - | $ 18.8 B | ||
|
DexCom
DXCM
|
13.5 | $ 67.97 | 0.59 % | $ 26.2 B | ||
|
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
1.65 | $ 26.61 | -0.41 % | $ 805 M | ||
|
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
1.86 | $ 19.07 | -2.1 % | $ 1.03 B | ||
|
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
0.337 | $ 3.16 | -1.25 % | $ 101 K | ||
|
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
2.31 | $ 226.1 | -0.36 % | $ 41 B | ||
|
Guardant Health
GH
|
7.91 | $ 102.18 | -0.78 % | $ 12.5 B | ||
|
Myriad Genetics
MYGN
|
1.16 | $ 6.35 | -2.08 % | $ 575 M | ||
|
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.84 | -4.69 % | $ 2.6 M | ||
|
Neogen Corporation
NEOG
|
1.14 | $ 7.22 | 1.19 % | $ 1.57 B | ||
|
National Research Corporation
NRC
|
6.79 | $ 18.59 | -0.38 % | $ 456 M | ||
|
Koninklijke Philips N.V.
PHG
|
1.8 | $ 27.27 | 0.59 % | $ 20 B | ||
|
Personalis
PSNL
|
3 | $ 8.15 | 0.12 % | $ 483 M | ||
|
Quidel Corporation
QDEL
|
6.36 | $ 29.14 | -0.55 % | $ 1.23 B | ||
|
Illumina
ILMN
|
3.75 | $ 134.01 | -0.7 % | $ 21.3 B | ||
|
Charles River Laboratories International
CRL
|
2.11 | $ 203.03 | -0.26 % | $ 10.4 B | ||
|
RadNet
RDNT
|
2.01 | $ 73.16 | 0.01 % | $ 5.34 B | ||
|
Soleno Therapeutics
SLNO
|
9.03 | $ 47.85 | 0.42 % | $ 1.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.93 | $ 175.51 | -0.26 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
1.29 | $ 6.6 | -3.19 % | $ 856 M | ||
|
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
1.62 | $ 253.06 | -0.33 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
3.25 | $ 182.53 | -0.17 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
9.66 | $ 683.64 | -0.7 % | $ 56.4 B | ||
|
Lantheus Holdings
LNTH
|
4.21 | $ 67.05 | 0.51 % | $ 4.64 B | ||
|
Mettler-Toledo International
MTD
|
7.72 | $ 1 411.78 | -0.59 % | $ 30 B |